呼吸道感染的疾病负担分析与实验室检测技术的研究进展
摘要
属公共卫生重点关注议题。本文系统综述其流行病学特征、病原谱及耐药性变迁，拟为科学研究与临床诊疗提供数据支撑；
实验室检测层面，重点剖析传统检测局限与突破，探讨新兴检测技术的应用与前景，人工智能、大数据及新型检测技术正
推动 RI 诊疗精准化、智能化。未来，需聚焦创新检测技术研发、多靶点治疗探索及免疫调节与个体化治疗研究，提升 RI
诊疗与防控能力，对降低发病率、减轻全球疾病负担至关重要。
关键词
全文:
PDF参考
[1]Global Health Estimates: Life expectancy and leading
causes of death and disability[EB/OL].[2025-03-05].https://
www.who.int/data/gho/data/themes/mortality-and-global-health-
estimates.
[2] Bender RG, Sirota SB, Swetschinski LR, et al. Global,
regional, and national incidence and mortality burden of non-
COVID-19 lower respiratory infections and aetiologies, 1990–
2021: a systematic analysis from the Global Burden of Disease
Study 2021[J/OL]. Lancet Infect Dis, 2024: S1473309924001762.
[3] Li M, Song Z, Wan W, et al. Burden of non-COVID-19
lower respiratory infections in China (1990–2021): a global
burden of disease study analysis[J]. Respir Res, 2025, 26(1): 125.
[4] Zhang Y, Yuan L, Zhang Y, et al. Burden of respiratory
syncytial virus infections in China: systematic review and meta-
analysis[J]. J Glob Health, 2015.
[5] Zhang J, Yang T, Zou M, et al. The epidemiological
features of respiratory tract infection using the multiplex panels
detection during COVID-19 pandemic in Shandong province,
China[J]. Sci Rep, 2023.
[6] Grech AK, Foo CT, Paul E, et al. Epidemiological trends
of respiratory tract pathogens detected via mPCR in Australian
adult patients before COVID-19[J]. BMC Infect Dis, 2024.
[7] 中华医学会儿科分会呼吸学组 , 重庆市妇幼卫生学
会儿童健康专委会 , 中国医药卫生文化协会疫苗与健康分会 .
中国儿童呼吸道合胞病毒感染防控的专家倡议（2023）[J].
中华医学杂志 , 2023, 103(40): 3155-3159.
[8] Estimates of the global, regional, and national morbidity,
mortality, and aetiologies of lower respiratory infections in 195
countries, 1990-2016: a systematic analysis for the Global Burden
of Disease Study 2016[J]. Lancet Infect Dis, 2018.
[9] Zumla A, Al-Tawfiq JA, Enne VI, et al. Rapid point
of care diagnostic tests for viral and bacterial respiratory tract
infections--needs, advances, and future prospects[J]. Lancet
Infect Dis, 2014.
[10] Alpuche C, Garau J, Lim V. Global and local variations
in antimicrobial susceptibilities and resistance development in the
major respiratory pathogens[J]. Int J Antimicrob Agents, 2007.
[11] Mlynarczyk G, Mlynarczyk A, Jeljaszewicz J.
Epidemiological aspects of antibiotic resistance in respiratory
pathogens[J]. Int J Antimicrob Agents, 2001.
[12] Li Y, Liang E, Gao Y. Modeling and simulation of
distribution and drug resistance of major pathogens in patients
with respiratory system infections[J]. BMC Infect Dis, 2025.
[13] Xu J, Liu J, Li X, et al. Burden of bacterial antimicrobial
resistance in China: a systematic analysis from 1990 to 2021 and
projections to 2050[J]. J Adv Res, 2025.
[14] Du H, Li J, Wen H, et al. Respiratory pathogen profiles
of patients - Beijing Municipality, China, November 2023-April
2024[J]. China CDC Wkly, 2025.
[15] 王娜 , 李海 , 宋晶晶 , 等 . 人呼吸道合胞病毒检测
方法的研究进展 [J] . 中华预防医学杂志 , 2024, 58(8) : 1143-
1149.
[16] Liu Q, Jin X, Cheng J, et al. Advances in the application
of molecular diagnostic techniques for the detection of infectious
disease pathogens (Review)[J]. Mol Med Rep, 2023.
[17] Finch RG. Epidemiological features and chemotherapy of
community-acquired respiratory tract infections[J]. J Antimicrob
Chemother, 1990.
[18] 马鹏程 , 陈愉 . 呼吸道病原体检测方法研究进展 [J].
中国感染与化疗杂志 ,2024,24(01)：118-122.
[19] Calderaro A, Buttrini M, Farina B, et al. Respiratory
tract infections and laboratory diagnostic methods: a review with a
focus on syndromic panel-based assays[J]. Microorganisms, 2022.
(0 摘要 Views, 0 PDF Downloads)
Refbacks
- 当前没有refback。